New

Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

RSPHvsXLVIETF Comparison

ETF 1
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
-1.08%
VS
ETF 2
XLVI

State Street Health Care Select Sector SPDR Premium Income Fund

This fund is part of
Options Strategies
+0.26%

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belongs to the US Health Care segment. State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) is part of the Options Strategies segment. Both ETFs have the same top 3 sector exposures: and Health Care. RSPH is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.35% for XLVI. RSPH is down -3.91% year-to-date (YTD) with -$24M in YTD flows. XLVI performs better with -3.62% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of RSPH and XLVI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

RSPH vs XLVI performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Mar 24Mar 31Apr 8Apr 15Apr 22

Cumulative Flows

-12,000,000-10,000,000-8,000,000-6,000,000-4,000,000-2,000,0000Mar 24Mar 31Apr 8Apr 15Apr 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/24/2026
1M3MYTD1Y3Y5Y
Perf.
RSPH
XLVI
+1.26%+0.50%
-7.61%-5.57%
-3.91%-3.62%
+8.85%n/a
+3.16%n/a
+10.64%n/a
Flows
RSPH
XLVI
-$11M+$501K
-$24M+$2M
-$24M+$2M
-$107M-
-$335M-
-$180M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
RSPH
XLVI
+15.94%+13.09%
+16.25%n/a
+14.83%n/a
+16.23%n/a
Max drawdown
RSPH
XLVI
-10.87%-8.21%
-10.87%n/a
-17.06%n/a
-21.91%n/a
Max drawdown duration
RSPH
XLVI
54d54d
54dn/a
192dn/a
817dn/a
Trading data

Create an account to view trading data

Join for free
RSPH
XLVI
Last sale
4/27/2026 at 1:30 PM
$30.57
$24.56
Previous close
04/24/2026
$30.54
$24.65
Consolidated volume
04/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

XLVI
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
RSPH
XLVI
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/27/2026 at 1:30 PM
Live
Closed
RSPH
XLVI
Last price
$30.57
$24.56
1D performance
+0.10%
-0.34%
AuM$697.68 M$13.04 M
E/R0.4%0.35%
Characteristics
RSPH
XLVI
Management strategyPassiveActive
ProviderInvescoState Street Investment Management
BenchmarkS&P 500 Equal Weight Health Care Index-
N° of holdings5656
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2006July 30, 2025
ESGNoNo
Advertisement
Exposure

Countries

RSPH
USA
96.48%
Other
3.52%
XLVI
USA
96.44%
Other
3.56%

Sectors

RSPH
Health Care
93.2%
Other
6.8%
XLVI
Health Care
97.46%
Other
2.54%
Advertisement

Diversification

RSPH

Total weight of top 15 holdings out of 15

26.72%
XLVI

Total weight of top 15 holdings out of 15

70.36%

Top 15 holdings

Data as of March 31, 2026
RSPH
MERCK & CO INC
1.84%
WEST PHARM SVCS
1.83%
CIGNA
1.80%
HOLOGIC
1.79%
METTLER TOLEDO
1.79%
DAVITA INC
1.78%
BOSTON SCIENTIFIC
1.78%
PFIZER
1.77%
STERIS
1.77%
JOHNSON&JOHNSON
1.77%
HUMANA
1.77%
ELEVANCE HEALTH INC
1.77%
UNIVERSAL HEALTH SERVICES
1.77%
MEDTRONIC PLC
1.75%
US5049221055
1.75%
XLVI
LILLY
13.62%
JOHNSON&JOHNSON
11.01%
ABBVIE
7.19%
MERCK & CO INC
5.58%
UNITEDHEALTH GRP
4.58%
AMGEN-T
3.54%
THERMO FISHER SCIENTIFIC
3.45%
ABBOTT LABS
3.34%
GILEAD SCIENCES
3.23%
INTUITIVE SURGICAL
3.06%
PFIZER
2.98%
BRISTOL-MYERS SQUIBB
2.31%
DANAHER
2.23%
VERTEX PHARMACEUTICALS
2.12%
STRYKER
2.12%
Frequently asked questions about RSPH and XLVI

How have the RSPH and XLVI ETFs performed in 2026?

As of April 24, 2026, RSPH is down -3.91% year-to-date (YTD), while XLVI has lost -3.62%. That puts XLVI better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or XLVI?

Year-to-date, the RSPH ETF saw -$24M in flows, compared to +$2M for XLVI.

Which ETF is bigger: RSPH or XLVI?

As of April 24, 2026, RSPH holds $697.68 M in assets under management (AUM), while XLVI manages $13.04 M.

What sectors do the RSPH and XLVI ETFs invest in?

RSPH leans toward sectors like Health Care. Meanwhile, XLVI focuses on Health Care.

What are the top holdings of the RSPH ETF and XLVI ETF?

RSPH top holdings include MERCK & CO INC, WEST PHARM SVCS and CIGNA. XLVI holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: RSPH or XLVI?

RSPH holds 59 securities with 26.72% of its assets in the top 15. XLVI has 59 securities and a top 15 weight of 70.36%.

Advertisement
Latest news about RSPH & XLVI
Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast